The nurse receives the following information about a 51-year-old woman who is scheduled for a colonoscopy. Which information should be communicated to the health care provider before sending the patient for the procedure?
a. The patient has a permanent pacemaker to prevent bradycardia.
b. The patient is worried about discomfort during the examination.
c. The patient has had an allergic reaction to shellfish and iodine in the past.
d. The patient refused to drink the ordered polyethylene glycol (GoLYTELY).
d. The patient refused to drink the ordered polyethylene glycol (GoLYTELY).
If the patient has had inadequate bowel preparation, the colon cannot be visualized and the procedure should be rescheduled. Because contrast solution is not used during colonoscopy, the iodine allergy is not pertinent. A pacemaker is a contraindication to magnetic resonance imaging (MRI), but not to colonoscopy. The nurse should instruct the patient about the sedation used during the examination to decrease the patient's anxiety about discomfort.
You might also like to view...
Nursing research in the postmodern era of nursing has discovered which entity plays a key role in health and healing?
A) Consilience B) Spirituality C) Alternative interventions D) Complementary therapy
Anaphylactic shock is a:
1. Type I reaction, called immediate hypersensitivity reaction 2. Type II reaction, called cytotoxic hypersensitivity reaction 3. Type III allergic reaction, called immune complex hypersensitivity 4. Type IV allergic reaction, called delayed hypersensitivity reaction
Which of the following is initially appropriate in the management of a patient's diagnosed problem?
A. Inform the patient of the treatment plan. B. Give the patient detailed written instructions regarding the treatment plan. C. Inform the patient that the plan has been tailored to his or her needs. D. Inform the patient of treatment options and possible results.
Mr. Ralston has been using the transdermal patch for several years. What is his probable dosage?
a. 15 – 30 mg q 8 hours b. 4 mg PO tid c. 0.6 mg/hr d. 1 inch of 0.4% ointment